Although human gene sequences were historically patented, landmark US Supreme Court rulings such as Association for Molecular Pathology v. Myriad Genetics (2013) determined that naturally occurring DNA sequences are not patent-eligible.
While past practice saw thousands of gene patents granted, the landmark 2013 Supreme Court ruling in Association for Molecular Pathology v. Myriad Genetics decisively ended the patenting of isolated, naturally occurring human DNA sequences, making the claim false under current law.